Check the background of this firm on FINRA's BrokerCheck.

Leigh Baldwin & Co.

112 Albany Street, Cazenovia, NY 13035 | Phone: (315) 655-2964 Toll Free: 1-800-659-8044

Check the background of this firm on FINRA's BrokerCheck.

Day Traders Diary

1/22/09

U.S. stocks fell sharply at Thursday's start following more weak economic data and a surprise earnings miss at Microsoft. The Dow Jones Industrial Average fell 133 points to 8,095. The S&P 500 declined 15 points to 824, while the Nasdaq Composite shed 42 points to stand at 1,464. Not many stocks are trading higher. Microsoft is down 6%, rival Intel is cutting jobs. Sony expects a full year loss. Nokia and Ebay both missed estimates. The one tech that looks good today is Apple up 5% after easily beating estimates last night. The financials are mixed today. The financials trading lower on earnings include CIT Group, Huntington Bancshares, Janus, BB&T, SunTrust, and Fifth Third. M&T Bank and KeyCorp are actually higher following earnings. JP Morgan is up 2% as CEO Jamie Dimon bought $11 million worth of stock. Bank of America CEO bought a million dollars worth of his stock, but it isn't helping. A few stocks are trading higher on earnings including Lockheed Martin, Southwest Airlines, Unitedhealth Group, and Potash. After the first half an hour the averages remained weak near the lows of the day. Through the morning, the averages only got weaker. The financials are weak. It looks like John Thain is out at Merrill Lynch slash Bank of America. The insurance stocks are getting clobbered once again. Metlife and Hartford are both down 11%. Aflac is down 35%. Entering the lunch hour, the Dow was down 270 points. The Nasdaq declined 62 points. Very few stocks are in the green. In the afternoon the averages remained weak. Two financials, Goldman and Morgan Stanley rebounded moving into the green. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.